AXSM - Financial Reports List - Axsome Therapeutics, Inc. - IntrinsicAlpha

Axsome Therapeutics, Inc. AXSM

Healthcare - Biotechnology - NASDAQ - US

$ 103.47

-1.4 %

$ 5.05 B

Market Cap

-17.2

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	66.04%	24.06%	25.99%
Annual Report	FY	10-K	2024-12-31	42.53%	-20.05%	-21.02%
Quarterly Report	Q3	8-K	2024-09-30	81.27%	-3.86%	-0.81%
Quarterly Report	Q2	8-K	2024-06-30	86.65%	-18.13%	-19.97%
Quarterly Report	Q1	8-K	2024-03-31	-20.70%	-509.35%	-950.90%
Quarterly Report	Q4	8-K	2023-12-31	193.50%	-47.76%	-76.09%
Annual Report	FY	10-K	2023-12-31	440.80%	-20.97%	-31.34%
Quarterly Report	Q3	8-K	2023-09-30	243.08%	-31.68%	-46.32%
Quarterly Report	Q2	8-K	2023-06-30	429.49%	-56.81%	-62.48%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	72.62%	82.93%

1